Stuttgart - Delayed Quote • EUR Telix Pharmaceuticals Ltd (T3X.SG) Follow Compare 17.94 +0.48 +(2.72%) At close: January 31 at 2:46:13 PM GMT+1 Comparisons Indicators Technicals Corporate Events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for T3X.SG 1D 5D 6.82% 1M 24.67% 3M 43.69% 6M 84.00% YTD 24.67% 1Y 84.00% 5Y 84.00% All 84.00% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent News: T3X.SG View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform Telix Completes Acquisition of RLS (USA) Inc. ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery Illuccix® Receives European Approval Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference Telix Exceeds FY24 Guidance with US$142M Q4 Revenue Scintimun® Commercialization Partnership with Curium Pharma Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete